{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:26:57Z","timestamp":1781677617951,"version":"3.54.5"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/j.juro.2017.12.057","type":"journal-article","created":{"date-parts":[[2018,1,4]],"date-time":"2018-01-04T13:16:53Z","timestamp":1515071813000},"page":"1446-1451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Purified Protein Derivative Skin test prior to bacillus Calmette-Gu\u00e9rin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer"],"prefix":"10.1097","volume":"199","author":[{"given":"Naoya","family":"Niwa","sequence":"first","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeo","family":"Kosaka","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuichi","family":"Mizuno","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.12.057_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.12.057_bib2","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.6004\/jnccn.2016.0131","article-title":"NCCN Guidelines Insights: Bladder Cancer, Version 2.2016","volume":"14","author":"Clark","year":"2016","journal-title":"J Natl Compr Cancer Netw"},{"key":"10.1016\/j.juro.2017.12.057_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.12.057_bib4","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/cncr.30392","article-title":"Non-muscle-invasive bladder cancer: intravesical treatments beyond bacille Calmette-Gu\u00e9rin","volume":"123","author":"Packiam","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2017.12.057_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1464-410X.2012.11390.x","article-title":"Intravesical chemotherapy plus bacille Calmette-Gu\u00e9rin in non-muscle invasive bladder cancer: a systematic review with","volume":"111","author":"Houghton","year":"2013","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.12.057_bib6","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin with interferon-alpha versus intravesical bacillus Calmette-Gu\u00e9rin for treating non-muscle-invasive bladder cancer","volume":"3","author":"Shepherd","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.juro.2017.12.057_bib7","doi-asserted-by":"crossref","first-page":"137ra72","DOI":"10.1126\/scitranslmed.3003586","article-title":"Preexisting BCG-specific T cells improve intravesical immunotherapy for bladder cancer","volume":"4","author":"Biot","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.juro.2017.12.057_bib8","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0022-5347(17)53283-8","article-title":"Bladder cancer immunotherapy","volume":"128","author":"Lamm","year":"1982","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.12.057_bib9","first-page":"48","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin therapy for superficial bladder cancer: effect of bacillus Calmette-Gu\u00e9rin viability on treatment results","volume":"134","author":"Kelley","year":"1985","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.juro.2017.12.057_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1200\/JCO.1987.5.3.441","article-title":"A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Gu\u00e9rin therapy of superficial bladder cancer","volume":"5","author":"Badalament","year":"1987","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2017.12.057_bib11","doi-asserted-by":"crossref","first-page":"77.e15","DOI":"10.1016\/j.urolonc.2017.10.005","article-title":"Purified protein derivative skin test reactions are associated with clinical outcomes of patients with nonmuscle invasive bladder cancer treated with induction bacillus Calmette-Gu\u00e9rin therapy","volume":"36","author":"Niwa","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.juro.2017.12.057_bib12","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1164\/ajrccm.159.1.9801120","article-title":"Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion","volume":"159","author":"Menzies","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.juro.2017.12.057_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.eururo.2003.09.018","article-title":"Handling and pathology reporting of specimens with carcinoma of the urinary bladder, ureter, and renal pelvis","volume":"45","author":"Lopez-Beltran","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.12.057_bib14","series-title":"TNM Classification of Malignant Tumours, 7th ed","first-page":"262","article-title":"Urinary bladder (ICD-O C67)","author":"Sobin","year":"2009"},{"key":"10.1016\/j.juro.2017.12.057_bib15","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.urology.2008.12.039","article-title":"Discontinuance of bacille Calmette-Gu\u00e9rin instillation therapy for nonmuscle-invasive bladder cancer has negative effect on tumor recurrence","volume":"73","author":"Takeda","year":"2009","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.12.057_bib16","first-page":"181","article-title":"BCG-induced interleukin-6 upregulation and BCG internalization in well and poorly differentiated human bladder cancer cell lines","volume":"9","author":"Bevers","year":"1998","journal-title":"Eur Cytokine Netw"},{"key":"10.1016\/j.juro.2017.12.057_bib17","first-page":"4286","article-title":"Murine bladder carcinoma cells present antigen to BCG-specific CD4+ T-Cells","volume":"52","author":"Lattime","year":"1992","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2017.12.057_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2249.2006.03191.x","article-title":"Role of Th1-stimulating cytokines in bacillus Calmette- Gu\u00e9rin (BCG)-induced macrophage cytotoxicity against mouse bladder cancer MBT-2 cells","volume":"146","author":"Luo","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.juro.2017.12.057_bib19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/nrurol.2014.15","article-title":"The mechanism of action of BCG therapy for bladder cancer\u2014a current perspective","volume":"11","author":"Redelman-Sidi","year":"2014","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.juro.2017.12.057_bib20","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(98)07422-4","article-title":"BCG immunotherapy of bladder cancer: 20 years on","volume":"353","author":"Alexandroff","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2017.12.057_bib21","doi-asserted-by":"crossref","first-page":"3522","DOI":"10.1016\/j.vaccine.2006.02.005","article-title":"Protection against an aerogenic Mycobacterium tuberculosis infection in BCG-immunized and DNA-vaccinated mice is associated with early type I cytokine responses","volume":"24","author":"Goter-Robinson","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.juro.2017.12.057_bib22","series-title":"Elsevier\u2019s Integrated Review: Immunology and Microbiology, 2nd ed","article-title":"Adaptive immune response and hypersensitivity","author":"Actor","year":"2012"},{"key":"10.1016\/j.juro.2017.12.057_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.smim.2009.02.006","article-title":"CD4 memory T cells: what are they and what can they do?","volume":"21","author":"MacLeod","year":"2009","journal-title":"Semin Immunol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718300065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534718300065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.12.057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:04:45Z","timestamp":1651194285000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.12.057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6]]},"references-count":23,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["10.1016\/j.juro.2017.12.057"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.12.057","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Purified Protein Derivative Skin test prior to bacillus Calmette-Gu\u00e9rin Therapy May have Therapeutic Impact in Patients with Nonmuscle Invasive Bladder Cancer","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.12.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}